Revance Therapeutics Inc (RVNC)

[iwfal]

That +7% QoQ is stellar! RHA sucked but that could be transitory as mentioned on the call.

1) Sure, but it came via, effectively, price cuts. Unit sales were up from Q4, $ down.

2) When asked to comment on data-seen-to-date in Q2 Foley put much more emphasis on RHA picking up, and just gave bland words on Daxxy early Q2 data. Its not clear they know how to get Daxxi into new accounts? Further he noted that the assumption for the predicted 2024 revenue of $280M is that more than half is RHA.. They're going to be more an RHA company in 2024 than a Daxxy company..